Related Experiment Video
Updated: Jul 17, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Cyclooxygenase-2: a novel target in human solid tumors.
Maria Rosaria Raspollini1, Gian Luigi Taddei
1Department of Human Pathology and Oncology, University of Florence, School of Medicine, Viale G.B. Morgagni, 85. 50134 Florence, Italy. mariarosaria.raspollini@unifi.it
Cyclooxygenase-2 (COX-2) inhibitors show promise in treating inflammatory diseases and cancers by targeting prostanoid synthesis. These agents may offer new chemopreventive strategies and personalized treatments for solid tumors.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Cyclooxygenase-2 (COX-2) is crucial in inflammatory and proliferative processes.
- Prostaglandins, synthesized via COX-2, are implicated in inflammatory diseases and cancer development.
- COX inhibitors demonstrate potential in cancer prevention and treatment.
Purpose of the Study:
- To explore the role of COX-2 in inflammation and cancer.
- To evaluate the therapeutic potential of COX inhibitors in oncology.
- To highlight the promise of targeted cancer therapies based on molecular tumor characteristics.
Main Methods:
- Review of experimental data on COX-2 and prostaglandins.
- Analysis of studies on COX inhibitors in cancer chemoprevention.
- Examination of evidence supporting targeted therapies for solid cancers.
Main Results:
- COX-2 plays a key role in inflammatory and proliferative reactions.
- Prostaglandins are central to the therapeutic targeting of inflammatory diseases and cancers.
- COX inhibitors show protective effects against carcinoma development.
Conclusions:
- COX inhibitors are promising chemopreventive agents and potential target therapies for cancer.
- New cancer treatments can be developed by tailoring therapies to individual tumor molecular profiles.
- Targeting COX-2 offers a viable strategy for managing inflammatory diseases and various human cancers.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
